Variant report
Variant | nsv818273 |
---|---|
Chromosome Location | chr4:133685637-133731875 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150029664 | chr4:133687805-133687806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6821730 | chr4:133687832-133687833 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs535459416 | chr4:133687838-133687839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555436208 | chr4:133687851-133687852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572486932 | chr4:133687868-133687869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs60969303 | chr4:133687884-133687885 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs560062927 | chr4:133687942-133687943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576983460 | chr4:133687946-133687947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182076909 | chr4:133687974-133687975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562776693 | chr4:133688010-133688011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531332950 | chr4:133688015-133688016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548249896 | chr4:133688020-133688021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115926572 | chr4:133688021-133688022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs111377749 | chr4:133688071-133688072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554632309 | chr4:133688103-133688104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186053279 | chr4:133688114-133688115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544432065 | chr4:133688122-133688123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372110462 | chr4:133688190-133688191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540030054 | chr4:133688204-133688205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574474076 | chr4:133688249-133688250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs550014773 | chr4:133688293-133688294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570061124 | chr4:133688307-133688308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs55935253 | chr4:133688426-133688427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535447601 | chr4:133688438-133688439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs192016275 | chr4:133688510-133688511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566088750 | chr4:133688603-133688604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534776175 | chr4:133688617-133688618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs145431905 | chr4:133688655-133688656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181198940 | chr4:133688657-133688658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186386096 | chr4:133688677-133688678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs35905356 | chr4:133688687-133688688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562905365 | chr4:133688693-133688694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191236617 | chr4:133688696-133688697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149215678 | chr4:133688700-133688701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs62314201 | chr4:133688753-133688754 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs527294228 | chr4:133688773-133688774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540725584 | chr4:133688774-133688775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182636694 | chr4:133688803-133688804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs145140322 | chr4:133688815-133688816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533346754 | chr4:133688822-133688823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550000622 | chr4:133688836-133688837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569998459 | chr4:133688841-133688842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529517549 | chr4:133688853-133688854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368045754 | chr4:133688916-133688917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs62314202 | chr4:133688963-133688964 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs565894740 | chr4:133689015-133689016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79272873 | chr4:133689042-133689043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs77881313 | chr4:133689061-133689062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186660548 | chr4:133689071-133689072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs138529291 | chr4:133689099-133689100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Mental retardation | 17847001 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Mental retardation | 17901693 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:133687800-133689400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr4:133688800-133689400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr4:133690200-133690600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr4:133690200-133692400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr4:133709600-133710000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr4:133714200-133715000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
7 | chr4:133719000-133719400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr4:133730200-133732600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr4:133730600-133731000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |